The Chester Pierce Research Society (CPRS) is an annual speaker series named in honor of the late Professor Emeritus in Psychiatry Chester Pierce, MD, the first African-American physician-scientist and full professor at Mass General. CPRS exposes the Mass General community to novel basic science, clinical, translational, health services and disparities research by our talented URM physicians and scientists.

Upcoming Speaker Series

October 22, 2021

12 pm–1 pm
cdi@mgh.harvard.edu
To RSVP, please click here.

Obesity in Pediatrics: Our Understanding and Consideration of Pharmacologic and Surgical Treatment Approaches

Fatima Cody StanfordFatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Obesity Medicine Physician for Adults, Adolescents, and Children, MGH Weight Center
Director of Equity, MGH Medicine – Endocrine Division
Director of Diversity, Nutrition Obesity Research Center at Harvard (NORCH)
CoreFaculty, MGH Mongan Institute of Health Policy
Leadership Team, MGH Midlife Women’s Health Center
Assistant Professor – Medicine & Pediatrics, Harvard Medical School

Dr. Stanford is an obesity medicine physician at Massachusetts General Hospital (MGH)/Harvard Medical School (HMS). She completed her Obesity Medicine & Nutrition Fellowship at MGH/HMS. Dr. Stanford received her BS and MPH from Emory University as an MLK Scholar, her MD from the Medical College of Georgia School of Medicine as a Stoney Scholar, and her MPA from the Harvard Kennedy School of Government as a Zuckerman Fellow in the Harvard Center for Public Leadership. Dr. Stanford completed her internal medicine and pediatrics residency at the University of South Carolina School of Medicine/Palmetto Health where she served as chief resident. She has served as a health communications fellow at the Centers for Disease Control and Prevention and as a behavioral sciences intern at the American Cancer Society. Upon completion of her MPH, she received the Gold Congressional Award, the highest honor that Congress bestows upon America’s youth. Dr. Stanford has completed a medicine and media internship at the Discovery Channel. An American Medical Association (AMA) Foundation Leadership Award recipient in 2005, an AMA Paul Ambrose Award for national leadership among resident physicians in 2009, she was selected for the AMA Inspirational Physician Award in 2015. The American College of Physicians (ACP) selected her as the 2013 recipient of the Joseph E. Johnson Leadership Award and the Massachusetts ACP selected her for the Young Leadership Award in 2015. She is the 2017 recipient of the Harvard Medical School Amos Diversity Award and Massachusetts Medical Society Award for Women’s Health. In 2019, she was selected for the Massachusetts Medical Society Suffolk Community Clinician of the Year and Reducing Health Disparities award. In 2020, she was elected as the American Medical Association Chair of the Minority Affairs Section, and she was selected as one of the inaugural recipients of the MGH Anne Klibanski Visiting Scholar Award. She was selected for The Obesity Society Clinician of the Year in 2020. In 2021, she has been awarded the MMS Grant Rodkey Award for her dedication to medical students and the AMA Dr. Edmond and Rima Cabbabe Dedication to the Profession Award which recognizes a physician who demonstrates active and productive improvement to the profession of medicine through community service, advocacy, leadership, teaching, or philanthropy. She is the 2021 Recipient of the Emory Rollins School of Public Health Distinguished Alumni Award.

Future Presenters – Save the Date

More details will follow closer to the dates.

January 20, 2022

12 pm–1 pm
To RSVP, please click here.

The Evolving Role of Neuroimaging in Alzheimer's Disease: From Symptoms to In Vivo Biology  

Julie PriceJulie Price, PhD
Director, PET Pharmacokinetic Modeling, Athinoula A. Martinos Center for Biomedical Imaging Investigator, Department of Radiology
Professor of Radiology, Harvard Medical School
Faculty Co-Director for Research, MGH Center for Diversity and Inclusion

Julie Price, PhD is an Investigator and Professor in the Department of Radiology at Massachusetts General Hospital, Harvard Medical School and Director of PET Pharmacokinetic Modeling at the Athinoula A. Martinos Center for Biomedical Imaging. Her expertise is in PET imaging methodology for translational imaging of protein targets in aging, neurodegeneration, and neuropsychiatric disorders. Her primary PET research is focused on in vivo quantification of amyloid-beta and tau deposits in neurodegeneration. She completed physics (BS) and medical physics (MS) degrees at the University of Wisconsin-Madison, doctoral training (specializing in radiation health sciences) at Johns Hopkins University (PhD), and postdoctoral training at the NIH PET/Nuclear Medicine Department. She served as Chair of the NIH Clinical Neuroscience and Neurodegeneration study section (2013-2015) and on the Advisory Council to the Director of NIH Center for Scientific review (2017-2021). She is a 2021 Fellow of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), 2021 SNMMI Brain Imaging Council Kuhl-Lassen awardee, and a recipient of the MGH Department of Radiology Thrall mentoring award.

April 14, 2022

12 pm–1 pm

Cesar CastroCesar Castro, MD, MMSc
Director, Cancer Program, MGH Center for Systems Biology
Attending Physician, MGH Cancer Center
Associate Professor of Medicine, Harvard Medical School

 

Previous Speaker Series

July 27, 2021

"Clinical Translation of Genetic Predictors for Type 2 Diabetes"

Jose Florez, MDJose Florez, MD
Department of Medicine, Diabetes Unit
Chief, Endocrine Division and Diabetes Unit
Professor of Medicine, Harvard Medical School
Institute Member, Broad Institute

Dr. Florez is the Chief of the Endocrine Division and the Diabetes Unit at the MGH, where he holds the John T. Potts Jr., MD Endowed Chair in Medicine. He is also Professor of Medicine at Harvard Medical School, and an Institute Member at the Broad Institute. He and his group have contributed to the performance and analysis of high-throughput genomic studies in type 2 diabetes and related traits, in international consortia such as MAGIC, GENIE, DIAGRAM, T2D-GENES, AMP-T2D, SIGMA and RADIANT, where he plays management roles. He leads the genetics initiatives of the Diabetes Prevention Program and the GRADE clinical trial, where the effects of genetic variants on specific behavioral and pharmacological preventive interventions can be assessed. He is the Principal Investigator of the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH), and also conducts other pharmacogenetic studies at MGH. He is an author on 200+ original publications and 50+ reviews/book chapters. In addition to his research and teaching duties, he is clinically active in the MGH Diabetes Center, the Endocrine inpatient consult service, and the MGH Down Syndrome Program. In 2007 he received an MGH Physician-Scientist Development Award (PSDA) and he is a recipient of the 2010 Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their independent research careers. In 2019 he received the Father of the Year award from the American Diabetes Association.

2019 Lecture: Why Do So Many Black People Have Kidney Disease? Insights from Human Stem Cell-Derived Podocytes

Opeyemi Olabisi, MD, PhD
2019 Speaker Opeyemi Olabisi, MD, PhD

2019 speaker Opeyemi Olabisi, MD, PhD, is a physician in the Nephrology Division of the Mass General Department of Medicine and Assistant Professor of Medicine at Harvard Medical School. Dr. Olabisi graduated in 2001 from The City College of New York with a bachelor’s degree in Biology and received his MD, PhD degree in 2009 from Albert Einstein College of Medicine, where he studied the regulation of the NFAT transcription factor. He came to Mass General in 2009, completed a residency in internal medicine, and subsequently completed a fellowship in the combined Mass General-Brigham & Women's nephrology fellowship program. Dr. Olabisi recognizes that an effective approach to reducing the mortality associated with chronic kidney disease (CKD) is to reduce the rate of progression of CKD to end stage kidney disease (ESKD). This passion motivates his ongoing research of the mechanism by which mutations in ApoL1 gene accelerate progression of CKD to ESKD. Early in 2015, he joined the Faculty of Renal Division in Mass General Department of Medicine. In support of his work, Dr. Olabisi recently received the 2015 Harold Amos Medical Faculty Development Award from the Robert Wood Johnson Foundation.

2017 Lecture: Overcoming Immunosuppression to Treat Malignant Brain Tumors

William T. Curry, Jr., MD
2017 Speaker William T. Curry, Jr., MD

On July 6, 2017, William T. Curry, Jr., MD delivered the CPRS lecture titled “Overcoming Immunosuppression to Treat Malignant Brain Tumors.” Dr. Curry conducts translational research in immunotherapy for malignant brain tumors. One current focus is on achieving representative ethnic diversity in cancer clinical trials and understanding ethnic variations in biological responses to therapies. Early in his career, he was awarded the 2006 Physician/Scientist Development Award, which helped support his translational research focus. Dr. Curry is the first African American full professor in Neurosurgery at Mass General. He is the director of Neurosurgical Oncology with a clinical practice that focuses on caring for patients with benign and malignant tumors of the brain and cranial base.